According to firm's 1984 annual report, its subsidiary Material Processing Technology, Inc., contributed $2.2 mil. in sales, or 97% of PharmaControl's entire sales revenue of $2.3 mil. PharmaControl's primary customer, Monsanto, provided $1.8 mil., or 82% of MPT's consolidated sales for the year ended June 30, 1984
You may also be interested in...
If President Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsberg, Affordable Care Act coverage could disappear. See what Kyle Sampson, a partner with the Washington, DC law firm King & Spalding said about it here.
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.
Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.